These data suggest that CCL5 may be important in type 1 diabetes and obesity, but more research is needed to evaluate the role of CCL5 in diabetic neuropathy and obesity-induced hypersensitivity. This evidence concerns the gene CCL5 and type 1 diabetes mellitus.